Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Granules Life Sciences Pvt. Ltd.
483
•Granules Life Sciences Pvt. Ltd.•August 1, 2025

Granules Life Sciences Pvt. Ltd. – FDA 483, Aug 1, 2025

Record Details

During an inspection conducted by the U.S. Food and Drug Administration (FDA) from July 28 to August 1, 2025, Granules Life Sciences Pvt. Ltd., a drug manufacturing facility located in Medchal-Malkajgiri District, Telangana, India, received a Form FDA 483. The primary observation cited a lack of appropriate controls over computer and related systems, failing to ensure that changes to master production, control, and other critical records are instituted only by authorized personnel. Investigators noted several specific issues, including the use of shared usernames and passwords for various Human Machine Interface (HMI) systems and laboratory testing equipment, which are used in manufacturing drug products for the U.S. market. Additionally, systems allowed alarm acknowledgments without proper sign-in, and in-process testing equipment permitted operators to overwrite previous results and alter program parameters. Critical laboratory instruments, such as scales, balances, and analytical equipment used for material and product testing, lacked individual username privileges and password protection. These findings indicate deficiencies in data integrity and system security, which are essential under drug manufacturing regulations. Granules Life Sciences Pvt. Ltd. is required to assess these observations and implement effective corrective actions to resolve the identified control lapses.

Company
Granules Life Sciences Pvt. Ltd.
Inspection date
August 1, 2025
Product type
drugs
Office
Office of Inspections and Investigations
Person
  • Lori B. Wilkstrom
View Company Profile

ID · 9a62e127-0235-4ac8-8e37-5b74cf6aaf6c

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Granules Life Sciences Pvt. Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.